REGISTERED
on 10 Dec 2019
Last Applicant/ Owned by
4242 Campus Point Court, Suite 200
San Diego
CA
92121
Serial Number
87893278 filed on 25th Apr 2018
Registration Number
5932962 registered on 10th Dec 2019
Correspondent Address
Beth M. Goldman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CINVANTI (APREPITANT) INJECTABLE EMULSION
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Classification Information
Class [005]
Pharmaceutical Products
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
First Use Date in General
22nd Oct 2019
First Use Date in Commerce
22nd Oct 2019
Mark Details
Serial Number
No 87893278
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 21539-6000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.21 -
Triangles that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Aug 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 10th Dec 2019 | REGISTERED-PRINCIPAL REGISTER |
| 06th Nov 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Nov 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th Oct 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Oct 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Oct 2019 | SOU EXTENSION 2 GRANTED |
| 29th Oct 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| 24th Oct 2019 | TEAS STATEMENT OF USE RECEIVED |
| 24th Oct 2019 | SOU TEAS EXTENSION RECEIVED |